Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 875 of 2228 entries
View as:

Pharmacokinetics of Salmeterol (Serevent®) After Inhalation With Metered Dose Inhaler (MDI) and Diskus® in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02254226 Org: User:
Start: 11/30/04 End: - Due: -

A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

Phase: N/A Priority: Normal
NCT ID: NCT06769048 Org: User:
Start: 01/31/25 End: 12/31/26 Due: 12/31/27

Empa PASS on Urinary Tract Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03464045 Org: User:
Start: 11/16/16 End: 03/11/24 Due: 03/11/25

The Ability of Songha Night ® to Improve Sleep in Patients With Mild to Moderate Sleep Disturbances

Phase: N/A Priority: Normal
NCT ID: NCT02183714 Org: User:
Start: 05/31/98 End: - Due: -

A Multi-centre 3-arm Randomised Phase II Trial of BIBF 1120 Versus BIBW 2992 Versus Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Hormone-resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00706628 Org: User:
Start: 03/31/06 End: - Due: -

Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

Phase: N/A Priority: Normal
NCT ID: NCT05819398 Org: User:
Start: 04/17/23 End: 03/31/25 Due: 03/31/26

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT06632444 Org: User:
Start: 10/14/24 End: 12/27/31 Due: 12/27/32

BI 10773 add-on to Metformin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00749190 Org: User:
Start: 08/31/08 End: - Due: -

12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD

Phase: N/A Priority: Normal
NCT ID: NCT00240435 Org: User:
Start: 11/30/02 End: - Due: -

Phase I Dose Escalation of i.v. BI 836909 Monotherapy in Last Line Multiple Myeloma Patients

Phase: N/A Priority: Normal
NCT ID: NCT02514239 Org: User:
Start: 07/08/15 End: 07/02/20 Due: 07/02/21

A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

Phase: N/A Priority: Normal
NCT ID: NCT05282121 Org: User:
Start: 06/28/22 End: 06/07/24 Due: 06/07/25

Pharmacodynamic Effects, Safety and Tolerability of Cilobradine, to Healthy Male and Female Volunteers, With an Intra-individual Comparison to Moxifloxacin in a Subset of Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02264015 Org: User:
Start: 01/31/04 End: - Due: -

A Study in Healthy Men to Test Whether Bosentan Influences the Amount of BI 425809 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT05723874 Org: User:
Start: 03/06/23 End: 05/26/23 Due: 05/26/24

A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 764198 is Processed in the Body

Phase: N/A Priority: Normal
NCT ID: NCT04176536 Org: User:
Start: 12/10/19 End: 11/17/20 Due: 11/17/21

Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of KUC 7483 CL Tablets in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02259764 Org: User:
Start: 08/31/04 End: - Due: -

Investigation of the Metabolism and Pharmacokinetics of 10 mg [14C] BI 1356 Administered Orally Compared to 5 mg [14C] BI 1356 Administered Intravenously in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02183610 Org: User:
Start: 07/31/06 End: - Due: -

Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02392468 Org: User:
Start: 04/15/15 End: 08/10/17 Due: 08/10/18

Observational Non-interventional Study With Spiriva in Chronic Obstructive Pulmonary Disease Patients With Exercise-induced Dyspnoea

Phase: N/A Priority: Normal
NCT ID: NCT00540163 Org: User:
Start: 04/30/07 End: - Due: -

Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type

Phase: N/A Priority: Normal
NCT ID: NCT02249351 Org: User:
Start: 12/31/99 End: - Due: -

Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT02853123 Org: User:
Start: 09/22/16 End: 08/14/17 Due: 08/14/18

Olodaterol Bridging Study in Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01428622 Org: User:
Start: 10/31/11 End: - Due: -

BIBR 277 Capsules in Hypertensive Patients With Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT02187484 Org: User:
Start: 08/31/98 End: - Due: -

LUME BioNIS: a Biomarker Study in Patients With NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT02671422 Org: User:
Start: 03/09/16 End: 09/03/19 Due: 09/03/20

A Study to Test Different Doses of BI 3011441 in Japanese People With Different Types of Advanced Cancer (NRAS/KRAS Mutation Positive)

Phase: N/A Priority: Normal
NCT ID: NCT04742556 Org: User:
Start: 03/15/21 End: 10/20/22 Due: 10/20/23

Pharmacokinetics, Safety and Tolerability of the Combination of BI 207127 and Faldaprevir in Renal Impaired Patients

Phase: N/A Priority: Normal
NCT ID: NCT01957657 Org: User:
Start: 10/31/13 End: 12/31/13 Due: 12/31/14